Comparative effectiveness of three devices for transcatheter closure of atrial septal defects in adults (Trio-ASD): A pilot randomized trial

三种经导管封堵成人房间隔缺损装置 (Trio-ASD) 的有效性比较：一项随机试验

• 批准号: 452502
• 负责人: Horlick Eric
• 金额: $ 20.34万
• 依托单位: University Health Network (Toronto)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-09-01 至 2023-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=452502&lang=en
• 关键词: Atrial Septal Defect (Asd); Devices For Transcatheter Asd Closure; Pan-Canadian Network; Registry-Based Randomized Controlled Trial

Atrial septal defect (ASD) is one of the most common congenital heart defects. ASD is a hole in the wall that separates left and right sides of heart and prevents the mixing of oxygen-rich and oxygen-poor blood. The defect can be diagnosed early in child

房间隔缺损（ASD）是最常见的先天性心脏病之一。 ASD是心脏壁上的一个洞，将心脏的左右两侧分开，阻止富氧和贫氧血液的混合。这种缺陷可以在儿童早期被诊断出来